GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...
Adults aged 60 and over with underlying co-morbidities are at high risk of developing severe infections from RSV Vaccine showed 82.6% overall vaccine efficacy against RSV-LRTD with 94.6% efficacy ...
NHL fans displeased with Wayne Gretzky's new commercial for AREXVY vaccine. (Image Source: Imagn). NHL fans have expressed their dissatisfaction on social media regarding Wayne Gretzky's latest ...
Survey reveals gaps in vaccination intentions for flu, COVID-19, respiratory syncytial virus, and pneumococcal disease.
Getting vaccinated is one of the most effective ways to protect yourself and your loved ones from the flu, COVID-19 and RSV.
The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...
As the Centers for Disease Control and Prevention (CDC) finds that only one-quarter of older adults have received their ...
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback